OCD Trial, Recruiting NCT07024758 Sponsor: Baylor College of Medicine Condition: OCD
Back to Ocd

OCD Trial, Recruiting

NCT07024758
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The child is between 7 and 17 years old at the time of joining the trial.
  • The child has noticeable symptoms of anxiety and/or OCD, shown by a score of 12 or higher on a standard anxiety rating scale called the PARS.
  • The child's main problem is anxiety or OCD, confirmed through a structured interview used by the study team.
  • One parent or guardian is able and willing to take part in the assessments and treatment sessions throughout the study.
  • The participating parent or guardian lives with the child at least half of the time.
  • Both the parent/guardian and the child can read and understand English.
  • The child has an IQ above 69, based on a test or a professional's judgement (a previous assessment report may be accepted).
  • The child and family must be located in the state of Texas for treatment sessions and assessments.

Who may not be able to join:

  • The child has ever been diagnosed with a psychotic disorder or conduct disorder.
  • The child is currently experiencing serious thoughts of harming themselves or others, or has self-harmed in a way that required medical attention.
  • The child has very limited ability to communicate verbally (for example, cannot speak independently).
  • The child is currently receiving talk therapy that focuses mainly on anxiety or OCD (though pausing that therapy to join this study may be an option — confirm with trial site).
  • The child started a new antidepressant medication within the last 12 weeks before assessment, or started certain other psychiatric medications within the last 4 weeks (confirm with trial site for specific medication types).
  • The child's dose of any psychiatric medication was changed within the last 4 weeks before assessment, or within 2 weeks for certain medication types (confirm with trial site for specific medication types).
  • The child needs a higher level of care than this study can provide, such as having serious, active thoughts of suicide.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (339)-999-7590

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 July 2025
Est. completion
30 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in clinician-rated child anxiety severity (PARS) throughout the past week.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov